NCI-supported scientists BCMHouston and St. Jude Research recently found that an epigenetic modification involving serotonin (a substance that nerves use to send messages to one another) may drive the growth of a rare #BrainTumor in children. go.nih.gov/1YKLXv2 #BTSM

A 2023 Review in Science Translational Medicine looks at the complex connections between astrocytes and other types of cells in the nervous system, including neurons, oligodendrocytes, and microglia. Learn more: bit.ly/4esssnw #ScienceMagArchives

Very cool indeed !

Gliocidin can target brain tumours by disrupting the production of nucleotides needed for cell growth. The molecule’s unusual ability to cross the blood–brain barrier suggests a promising way to develop therapies go.nature.com/4fXuaOC

Our recent report presents an ambitious road map for better understanding #RNA, inspired by what was achieved for DNA two decades ago by the Human Genome Project. Learn about the report from a recent Issues in Science and Technology podcast: ow.ly/S3LW50UgVUo

A new @SciSignal study deciphers the molecular “grammar” of cytokine signaling in cells, showcasing how members of the JAK family of enzymes can compete to shape the activities of different immune cells. scim.ag/3B3URmk

Research reveals how brain tumors use the body’s circadian rhythms to grow, with implications for timing cancer treatments. hubs.ly/Q02_GkMr0

Daily glucocorticoids promote glioblastoma growth and circadian synchrony to the host: Cancer Cell cell.com/cancer-cell/fu… Great new paper from Erik Herzog and colleagues.

The book is now available in open access through Springer Neuromethods: link.springer.com/book/10.1007/9…. We extend our heartfelt thanks to all the contributing authors for their exceptional work, with special gratitude to Paul Thompson Paul Thompson for his inspiring foreword.

Nature research paper: Nucleosome fibre topology guides transcription factor binding to enhancers nature.com/articles/s4158…

One of the most bizarre + complex talks at NeurIPS [1] was given by my fellow Yorkshireman, the inimitable Prof Karl Friston [2], explaining active inference to a room full of #AI people who are not really neuroscientists. This was interesting to me because 💡Karl Friston is a

As we look forward to 2025, we take a moment to reflect on the remarkable accomplishments of the past year at the USC Brain Tumor Center. From advancing groundbreaking research to strengthening community outreach, education, and clinical care, 2024 has been an extraordinary year

Tip 5 for a happy and healthy holiday season: Spend 8 Minutes Outside! Sunlight helps reinforce your circadian rhythm, improving sleep and energy levels. Being outdoors calms the mind and body, helping you feel more refreshed and focused. Read all tips: ow.ly/5Kwv50UwxmM .

See what 2000+ ENIGMA Consortium scientists have been up to in 2024🎥youtu.be/lJ9ExmUe2Vg🧠Paul Thompson highlights discoveries in neuroimaging & genetics, drawing connections and new leads across brain diseases. Thank u to all members (pictured/nonpictured) + study participants🌎🌍🌏

Join us in making a difference this season! At the USC Brain Tumor Center, we are fueled by our mission to provide exceptional and innovative Brain Tumor Care. Your year-end donation plays a critical role in this mission. By directly supporting our cutting-edge research, you are

Great work by Bashor Lab in Science Magazine science.org/doi/10.1126/sc…

Petition to Reverse the NIH Indirect Cost Cap (NOT-OD-25-068) - Sign the Petition! chng.it/9RvpgmqSCg via Change.org

Alzheimer’s disease is likely caused by stalled protein processing in the brain, according to a new study. elifesciences.org/reviewed-prepr…

🌍 Today we stand with patients, caregivers, survivors, and researchers across the globe for World Brain Tumor Day. This is more than a diagnosis — it’s a community. Let’s honor those we've lost, uplift those still fighting, and commit to a future with more hope and healing.

A selection of preprints that I found interesting this week. They cover aging microglia, brain organoid models, computational pipelines, and proteome-scale AI. Contribute to open science & earn $150 for a high-quality review: